Related Experiment Video
Updated: Jul 1, 2025

Adjunctive Diode Laser Therapy and Probiotic Lactobacillus Therapy in the Treatment of Periodontitis and Peri-Implant Disease
Published on: May 9, 2022
PROPHYLACTIC ANTIBIOTICS DURING THE IMPLANT PROSTHETIC PHASE MAY NOT SUBSTANTIALLY DECREASE THE INCIDENCE OF
Preventive antibiotics are not routinely recommended during the prosthetic phase of dental implants for healthy patients. This systematic review found insufficient evidence to support their use, suggesting a need to reconsider current practices to avoid unnecessary antibiotic exposure.
Area of Science:
- Oral surgery
- Periodontology
- Infectious disease
Background:
- The prosthetic phase of dental implants involves placing the final restoration.
- Preventive antibiotic use during this phase is common but debated.
- Antibiotic resistance is a growing global health concern.
Purpose of the Study:
- To systematically review the literature on the necessity of preventive antibiotics during the prosthetic phase of dental implants in healthy patients.
- To evaluate the evidence supporting or refuting the routine prescription of antibiotics at this stage.
Main Methods:
- A systematic literature search was conducted across multiple databases.
- Studies evaluating antibiotic prophylaxis during the prosthetic phase of dental implants were included.
- Data on infection rates and antibiotic efficacy were extracted and analyzed.
Main Results:
- The available evidence does not support the routine use of preventive antibiotics in healthy patients during the prosthetic phase of dental implants.
- No significant difference in infection rates was observed between patients receiving and not receiving prophylactic antibiotics.
- The risk of adverse effects and the development of antibiotic resistance associated with unnecessary antibiotic use was highlighted.
Conclusions:
- Routine antibiotic prophylaxis is not justified for healthy patients undergoing the prosthetic phase of dental implants.
- Clinical decisions regarding antibiotic prescription should be based on individual patient risk factors and evidence-based guidelines.
- Minimizing unnecessary antibiotic exposure is crucial for combating antimicrobial resistance.
Related Concept Videos
Bacterial Signaling
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Tonsillitis II: Management
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...

